Mucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies

被引:14
|
作者
Aigbologa, Jessica [1 ]
Connolly, Maeve [2 ]
Buckley, Julliette M. [3 ,4 ]
O'Malley, Dervla [1 ,2 ]
机构
[1] APC Microbiome Ireland, Cork, Ireland
[2] Univ Coll Cork, Dept Physiol, Cork, Ireland
[3] Univ Coll Cork, Dept Surg, Cork, Ireland
[4] Mater Private Hosp, Cork, Ireland
来源
FRONTIERS IN PSYCHIATRY | 2020年 / 11卷
基金
爱尔兰科学基金会;
关键词
interleukin-25; irritable bowel syndrome; helminths; Wistar Kyoto; brush cells; Doublecortin Linked Kinase-1; DCAMKL1; chronic stress; GASTROINTESTINAL-TRACT; BRUSH CELLS; STRESS; IMMUNITY; IDENTIFICATION; INTERLEUKIN-6; DYSFUNCTION; PREVALENCE; MICROBIOTA; MEDIATORS;
D O I
10.3389/fpsyt.2020.00436
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Tuft cells are rare chemosensory sentinels found in the gut epithelium. When triggered by helminth infection, tuft cells secrete interleukin-25 (IL-25) basolaterally and subsequently evoke an immune response. Irritable bowel syndrome (IBS) is a common and heterogeneous disorder characterized by bowel dysfunction and visceral pain sensitivity. Dysfunctional gut-brain communication and immune activation contribute to the pathophysiology of this disorder. The study aims were to investigate changes in tuft cell density in non-post-infectious IBS patients. Immunofluorescent labeling of DCLK1-positive tuft cells was carried out in mucosal biopsies from the distal colons of diarrhea and constipation-predominant IBS patients and healthy controls. Tuft cell numbers were also assessed in animal models. Concentrations of interleukin-25 (IL-25) secreted from colonic biopsies and in plasma samples were analyzed using an immunoassay. The density of tuft cells was increased in diarrhea-but not constipation-predominant IBS patient colonic biopsies. Biopsy secretions and plasma concentrations of IL-25 were elevated in diarrhea-but not constipation-predominant IBS participants. Tuft cell hyperplasia was detected in a rat model of IBS but not in mice exposed to chronic stress. Tuft cell hyperplasia is an innate immune response to helminth exposure. However, the patients with diarrhea-predominant IBS have not reported any incidents of enteric infection. Moreover, rats exhibiting IBS-like symptoms displayed increased tuft cell density but were not exposed to helminths. Our findings suggest that factors other than helminth exposure or chronic stress lead to tuft cell hyperplasia in IBS colonic biopsies.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
    Sciume, Giusi Desire
    Berti, Ginevra
    Lambiase, Christian
    Paglianiti, Italia
    Villanacci, Vincenzo
    Rettura, Francesco
    Grosso, Antonio
    Ricchiuti, Angelo
    Bortoli, Nicola de
    Usai Satta, Paolo
    Bassotti, Gabrio
    Bellini, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (18)
  • [32] Profiling the Adherent Mucosal and Luminal Microbiota in Diarrhea-Predominant Irritable Bowel Patients
    Carroll, Ian M.
    Chang, Young-Hyo
    Sartor, R. Balfour
    Ringel, Yehuda
    GASTROENTEROLOGY, 2009, 136 (05) : A222 - A222
  • [33] POSTPRANDIAL PLASMA 5-HYDROXYTRYPTAMINE IS INCREASED IN DIARRHEA-PREDOMINANT IRRITABLE-BOWEL-SYNDROME
    BEARCROFT, CP
    PERRETT, D
    FARTHING, MJG
    GASTROENTEROLOGY, 1994, 106 (04) : A465 - A465
  • [34] COLONIC IMPAIRMENT OF INTESTINAL BARRIER INTEGRITY CORRELATES WITH SYMPTOMS IN DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME PATIENTS
    Cocca, S.
    Gori, M.
    Altomare, A.
    Emerenziani, S.
    Cicala, M.
    Guarino, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E74 - E75
  • [35] Acupuncture for diarrhea-predominant irritable bowel syndrome: A randomized control study
    Shen, Jiang-hong
    Ye, Yong-ming
    LI, Shan-shan
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2022, 32 (02) : 123 - 130
  • [36] Mesalamine alters colonic mucosal proteolytic activity and fecal bacterial profiles in diarrhea-predominant irritable bowel syndrome (IBS-D)
    Andrews, Christopher N.
    Petcu, Ruxandra
    Griffiths, Tanya
    Bjarnason, Jaime
    Chapman, Kevin
    Cellars, Laurie
    Vergnolle, Nathalie
    Rioux, Kevin P.
    GASTROENTEROLOGY, 2008, 134 (04) : A548 - A548
  • [37] Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome
    Dlugosz, A.
    Nowak, P.
    D'Amato, M.
    Mohammadian Kermani, G.
    Nystrom, J.
    Abdurahman, S.
    Lindberg, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (12): : 1747 - 1754
  • [38] Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
    Li, Pingping
    Zheng, Jimin
    Bai, Yun
    Wang, Dingxin
    Cui, Zijin
    Li, Yueqin
    Zhang, Jian
    Wang, Yuzhen
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2020, 64 : 14 - 21
  • [39] Patient-Centric Care of Diarrhea-Predominant Irritable Bowel Syndrome
    Lacy, Brian E.
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (08): : S43 - S48
  • [40] Evaluation of Crofelemer in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome Patients
    Mangel, Allen W.
    Chaturvedi, Pravin
    DIGESTION, 2008, 78 (04) : 180 - 186